adakveo
(crizanlizumab)Novartis Pharmaceuticals Corporation
Usage: ADAKVEO® is indicated for reducing the frequency of vaso-occlusive crises (VOCs) in adults and pediatric patients aged 16 and older with sickle cell disease.
28 results
cablivi
(caplacizumab)Genzyme CorporationUsage: CABLIVI is indicated for treating adult patients with acquired thrombotic thrombocytopenic purpura (aTTP), used alongside plasma exchange and immunosuppressive therapy.edarbi
(Azilsartan kamedoxomil)Azurity Pharmaceuticals, Inc.Usage: Edarbi is indicated for treating hypertension in adults to lower blood pressure, thereby reducing the risk of cardiovascular events such as strokes and myocardial infarctions. It can be used alone or with other antihypertensive medications as part of comprehensive cardiovascular risk management.edarbyclor
(Azilsartan kamedoxomil and chlorthalidone)Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)Usage: Edarbyclor is indicated for treating hypertension to lower blood pressure, particularly in patients not adequately controlled on monotherapy. It may also serve as initial therapy for those needing multiple drugs to reach blood pressure goals, reducing the risk of cardiovascular events like strokes and heart attacks.eliquis
(apixaban)E.R. Squibb & Sons, L.L.C.Usage: ELIQUIS is indicated to reduce the risk of stroke and systemic embolism in nonvalvular atrial fibrillation, as well as for the prophylaxis and treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE). It also reduces the risk of recurrence of DVT and PE post-therapy.feraheme
(ferumoxytol)AMAG Pharmaceuticals, Inc.Usage: Feraheme is indicated for treating iron deficiency anemia (IDA) in adult patients who are intolerant to oral iron, have had an unsatisfactory response to oral iron, or have chronic kidney disease (CKD).granix
(tbo-filgrastim)Cephalon, LLCUsage: GRANIX is indicated for reducing the duration of severe neutropenia in adults and pediatric patients (1 month and older) with non-myeloid malignancies undergoing myelosuppressive anticancer treatments that are likely to cause febrile neutropenia.inderal
(propranolol hydrochloride)ANI Pharmaceuticals, Inc.Usage: Inderal LA is indicated for managing hypertension (alone or with other agents), reducing angina frequency, prophylaxis of migraine headaches, and improving symptoms in patients with hypertrophic subaortic stenosis. It is not recommended for hypertensive emergencies or for treating acute migraine attacks.injectafer
(Ferric Carboxymaltose Injection)American Regent, Inc.Usage: Injectafer is indicated for treating iron deficiency anemia in patients aged 1 year and older with oral iron intolerance or unsatisfactory response, and in non-dialysis dependent chronic kidney disease. It also treats iron deficiency in adults with heart failure (NYHA class II/III) to improve exercise capacity.jesduvroq
(daprodustat)GlaxoSmithKline LLCUsage: JESDUVROQ is indicated for treating anemia due to chronic kidney disease (CKD) in adults on dialysis for at least four months. It is not a substitute for red blood cell transfusions and is not indicated for non-dialysis CKD patients. No evidence of improved quality of life or fatigue.